Acute Side Effects of Combined Chemotherapy with Intensity-Modulated Radiotherapy in The Treatment of Nasopharyngeal Carcinoma
Abstract
Nasopharyngeal cancer is a very common head and neck cancer. Although concurrent chemotherapy plays an important role in controlling the disease, the risk of acute toxicity is high due to the anatomical location of the tumor. The aim of our study is to evaluate the acute side effects observed in nasopharyngeal carcinoma patients who underwent definitive chemoradiotherapy. A total of 64 patients (41 men, 23 women) between the ages of 20 and 82, who were diagnosed with nasopharyngeal cancer and treated, were included in the study. All patients received concurrent chemoradiotherapy along with intensity-modulated radiotherapy. While 70 Gy radiotherapy was applied to the tumor and positive lymph nodes, 60 Gy radiotherapy was applied to the entire nasopharynx and bilateral neck lymph nodes. Three cycles of cisplatin 100 mg/m2 (days 1, 22 and 43) or weekly 40 mg/m2 cisplatin chemotherapy were used for treatment. Acute side effects of the patients were noted and evaluated. Of the patients included in the study, 15 (23%) had stage II disease, 37 (58%) had stage III disease, and 12 (19%) had stage IV disease. The rates of grade 2 and 3 hematological toxicity in male patients were 47% and 20%, respectively. The rates of grade 2 and 3 hematological toxicity in male patients were 47% and 20%, respectively. A significant difference was found in the hematological toxicity rate between both groups (p= 0.0001). In patients under the age of 65, grade 2 and 3 hematological toxicity rates were determined as 47% and 20%, respectively. In patients over 65 years of age, the rates of grade 2 and 3 esophagitis were 53% and 80%, respectively. There was a significant difference in the rate of esophagitis between both groups (p= 0.0001). Our results are compatible with the literature in terms of acute side effects. Close monitoring and treatment of acute side effects can improve patient compliance with treatment, improve quality of life, and increase the effectiveness of treatment.
Keywords
Project Number
2017-77
References
- Perez CA, Devineni VR, Marcial-Vega V, Marks JE, Simpson JR, Kucik N. Carcinoma of the nasopharynx: factors affecting prognosis. Int J Radiat Oncol Biol Phys. 1992; 23(2): 271-280. DOI: 10.1016/0360-3016(92)90741-y.
- Qin DX, Hu YH, Yan JH, et al. Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation. Cancer. 1988; 61(6): 1117-1124. DOI: 10.1002/1097-0142(19880315)61:6<1117::aid-cncr2820610611>3.0.co;2-j.
- Perez CA. Nasopharynx. In: Perez CA, Brady LW, eds. Principles and practice of radiation oncology, 4th ed. Philadelphia: Lippincot-Raven Publishers. 2004: 918-61.
- Tebra S, Kallel A, Boussen H, Bouaouina N. Traitements médicaux des carcinomes du nasopharynx [Medical treatment of nasopharyngeal cancers]. Tunis Med. 2011; 89(4): 326-331.
- Farias TP, Dias FL, Lima RA, et al. Prognostic factors and outcome for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2003; 129(7): 794-799. DOI: 10.1001/archotol.129.7.794.
- Xu YC, Chen KH, Liang ZG, Zhu XD. A Systematic review and meta-analysis of studies comparing concurrent chemoradiotherapy with radiotherapy alone in the treatment of stage II nasopharyngeal carcinoma. Front Oncol. 2022; 12: 843675. DOI: 10.3389/fonc.2022.843675.
- Begg AC. Cisplatin and radiation: interaction probabilities and therapeutic possibilities. Int J Radiat Oncol Biol Phys. 1990; 19(5): 1183-1189. DOI: 10.1016/0360-3016(90)90226-a.
- Qu S, Liang ZG, Zhu XD. Advances and challenges in intensity-modulated radiotherapy for nasopharyngeal carcinoma. Asian Pac J Cancer Prev. 2015; 16(5): 1687-1692. DOI: 10.7314/apjcp.2015.16.5.1687.
- Kang M, Wang F, Liao X, Zhou P, Wang R. Intensity-modulated radiotherapy combined with endostar has similar efficacy but weaker acute adverse reactions than IMRT combined with chemotherapy in the treatment of locally advanced nasopharyngeal carcinoma. Medicine (Baltimore). 2018; 97(25): e11118. DOI: 10.1097/MD.0000000000011118.
- O'Meara WP, Lee N. Advances in nasopharyngeal carcinoma. Curr Opin Oncol. 2005; 17(3): 225-230. DOI: 10.1097/01.cco.0000156197.29872.8e.